Edition:
United Kingdom

Ritter Pharmaceuticals Inc (RTTR.OQ)

RTTR.OQ on NASDAQ Stock Exchange Capital Market

0.85USD
16 Nov 2018
Change (% chg)

$-0.05 (-5.56%)
Prev Close
$0.90
Open
$0.84
Day's High
$0.89
Day's Low
$0.83
Volume
16,563
Avg. Vol
16,470
52-wk High
$3.99
52-wk Low
$0.80

Chart for

About

Ritter Pharmaceuticals, Inc. develops therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The Company's segment is focusing on the development and commercialization of RP-G28. The Company conducts human gut health research by exploring metabolic capacity of the gut microbiota and... (more)

Overall

Beta: --
Market Cap(Mil.): $5.57
Shares Outstanding(Mil.): 14.76
Dividend: --
Yield (%): --

Financials

  RTTR.OQ Industry Sector
P/E (TTM): -- 83.95 33.59
EPS (TTM): -1.44 -- --
ROI: -264.95 -0.80 15.05
ROE: -264.95 -0.14 16.62

Earnings vs. Estimates